« Previous
Next »
Titles
- Increases in reimbursement for brand-name drugs in Part D1
- Key design components and considerations for establishing a single-payer health care system: testimony before the Committee on the Budget, United States House of Representatives1
- Medicaid and personal responsibility waivers: opportunities and challenges in evaluating potential impacts1
- Medicaid changes in Better Care Reconciliation Act (BCRA) go beyond ACA repeal and replace1
- Medicaid: what we learned from the recent debate and what to watch for in September 20171
- Medicare Advantage 2017 spotlight: enrollment market update1
- Medicare Part D: a first look at prescription drug plans in 20191
- Medicare program shared savings accountable care organizations have shown potential for reducing spending and improving quality1
- New rules for Section 1332 waivers: changes and implications1
- Section 1115 Medicaid expansion waivers: implementation experiences : findings from structured interviews in Arkansas, Indiana, Iowa, & Michigan : final report1
- Short-term limited duration plans and HIV1
- Sources and preparation of data used in HISIM2: CBO’s health insurance simulation model1
- State marketplace stabilization strategies1
- Understanding the rules: federal legal considerations for state-based approaches to expand coverage in California1
- Using Medicaid to wrap around private insurance: key questions to consider1
- What's in the administration's 5-part plan for Medicare Part D and what would it mean for beneficiaries and program savings?1